104 related articles for article (PubMed ID: 3680302)
1. The activity of purified Bordetella pertussis components in murine encephalopathy.
Redhead K; Robinson A; Ashworth LA; Melville-Smith M
J Biol Stand; 1987 Oct; 15(4):341-51. PubMed ID: 3680302
[TBL] [Abstract][Full Text] [Related]
2. Pertussis toxin is required for pertussis vaccine encephalopathy.
Steinman L; Weiss A; Adelman N; Lim M; Zuniga R; Oehlert J; Hewlett E; Falkow S
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8733-6. PubMed ID: 2867545
[TBL] [Abstract][Full Text] [Related]
3. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin.
Steinman L; Weiss A; Adelman N; Lim M; Oehlert J; Zuniga R; Hewlett E; Falkow S
Dev Biol Stand; 1985; 61():439-46. PubMed ID: 2872126
[TBL] [Abstract][Full Text] [Related]
4. Murine responses to immunization with pertussis toxin and bovine serum albumin: I. Mortality observed after bovine albumin challenge is due to an anaphylactic reaction.
Wiedmeier SE; Chung HT; Cho BH; Kim UH; Daynes RA
Pediatr Res; 1987 Sep; 22(3):262-7. PubMed ID: 3309858
[TBL] [Abstract][Full Text] [Related]
5. Is the acute encephalopathy test in mice suited for control of pertussis vaccines?
Au-Jensen M; Heron I
Dev Biol Stand; 1985; 61():447-51. PubMed ID: 3835081
[TBL] [Abstract][Full Text] [Related]
6. Treatment of lethal pertussis vaccine reaction with histamine H1 antagonists.
Peroutka SJ; Kitamura K; Lim M; Steinman L
Neurology; 1987 Jun; 37(6):1068-72. PubMed ID: 2884595
[TBL] [Abstract][Full Text] [Related]
7. Mutants of pertussis toxin suitable for vaccine development.
Pizza M; Covacci A; Bartoloni A; Perugini M; Nencioni L; De Magistris MT; Villa L; Nucci D; Manetti R; Bugnoli M
Science; 1989 Oct; 246(4929):497-500. PubMed ID: 2683073
[TBL] [Abstract][Full Text] [Related]
8. Anaphylaxis or so-called encephalopathy in mice sensitized to an antigen with the aid of pertussigen (pertussis toxin).
Munoz JJ; Peacock MG; Hadlow WJ
Infect Immun; 1987 Apr; 55(4):1004-8. PubMed ID: 3557617
[TBL] [Abstract][Full Text] [Related]
9. Effect of hyperreactivity to endotoxin on the toxicity of pertussis vaccine and pertussis toxin in mice.
Sidey FM; Furman BL; Wardlaw AC
Vaccine; 1989 Jun; 7(3):237-41. PubMed ID: 2781857
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of active pertussis toxin may aid a pertussis vaccine to pass the mouse body weight gain test.
Horiuchi Y; Takahashi M; Asada S; Ishida S
Biologicals; 1994 Sep; 22(3):243-8. PubMed ID: 7811458
[TBL] [Abstract][Full Text] [Related]
11. Chick embryo, a model to study the lethal activity of pertussis toxin, infectivity of Bordetella pertussis, and their neutralization by immune sera.
Calver GA; Burton WW; Gardell CY
Can J Microbiol; 1993 Aug; 39(8):759-66. PubMed ID: 8106134
[TBL] [Abstract][Full Text] [Related]
12. The effects of purified components of Bordetella pertussis in the weight gain test for the toxicity testing of pertussis vaccines.
Redhead K; Seagroatt V
J Biol Stand; 1986 Jan; 14(1):57-65. PubMed ID: 2870067
[TBL] [Abstract][Full Text] [Related]
13. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
[TBL] [Abstract][Full Text] [Related]
14. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
[TBL] [Abstract][Full Text] [Related]
15. The pyrogenicity of pertussis vaccine in mice and the factors in the vaccine responsible for this effect.
Ishida S; Iwasa S; Fujiwara H; Chazono M; Akama K
J Biol Stand; 1989 Jan; 17(1):41-51. PubMed ID: 2784132
[TBL] [Abstract][Full Text] [Related]
16. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.
Petersen JW; Andersen P; Ibsen PH; Capiau C; Wachmann CH; Hasløv K; Heron I
Vaccine; 1993; 11(4):463-72. PubMed ID: 8470432
[TBL] [Abstract][Full Text] [Related]
17. Synergistic teratogenic effect produced in mice by whole cell pertussis vaccine.
Au-Jensen M; Heron I
Vaccine; 1987 Sep; 5(3):215-8. PubMed ID: 3673208
[TBL] [Abstract][Full Text] [Related]
18. Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model.
Olander RM; Muotiala A; Karvonen M; Kuronen T; Runeberg-Nyman K
Microb Pathog; 1990 Jan; 8(1):37-45. PubMed ID: 2159104
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxicity of Bordetella pertussis.
Pittman M
Neurotoxicology; 1986; 7(2):53-67. PubMed ID: 3024080
[TBL] [Abstract][Full Text] [Related]
20. Detoxification of Bordetella pertussis organisms or pertussis toxin with glutaraldehyde for preparation of pertussis vaccine.
Gupta RK
Vaccine; 1991 Sep; 9(9):690-1. PubMed ID: 1950101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
